Harvard Business School Launches Precision Trials Challenge
Harvard Business School has launched a competition to generate ideas to bring precision diagnostics and therapies to market more quickly by reinventing the clinical trials process.
The Health Care Initiative at Harvard Business School (HBS) has launched the Precision Trials Challenge (www.precisiontrialschallenge.org), a competition to generate ideas to bring precision diagnostics and therapies to market more quickly by reinventing the clinical trials process.
The challenge is open to all and will accept applications at (www.precisiontrialschallenge.org until March 13, 2016. A panel of judges will select one winner and two runners-up to share a $100,000 prize. The winner will be announced in April and have the opportunity to present at the prestigious 2016 Personalized Medicine Conference.
“Advancements in science and technology in the past ten years have led to great advances in precision medicine,” said HBS professor Richard Hamermesh. “However, many of the big challenges facing precision medicine today are actually business challenges. How can we develop business models that support the advancement of precision medicine? How can we get new therapies to market faster and at a lower cost? Our Precision Trials Challenge will help answer these questions by encouraging conversation and helping to put leading-edge ideas into practice.”
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
